IMPACT OF PHARMACIST LED INTERVENTION IN IMPROVING MEDICATION KNOWLEDGE AMONG CHRONIC KIDNEY DISEASE PATIENTS: A PRELIMINARY STUDY
Objective: This study aims to evaluate the impact of pharmacist-led medication management clinics in improving medication knowledge among chronic kidney disease (CKD) patients.
Methods: This was a retrospective study using a convenient sampling method. All CKD patients age 18 y above with complete pre and post knowledge assessment record were included. The pre-knowledge assessment was done at baseline while the post-assessment was done after a few sessions of medication knowledge teaching done by the clinical pharmacist using medication knowledge assessment form. Demographics data and pre-post knowledge scores were retrieved from patient’s electronic medical record system. All data were analysed using the Statistical Package for Social Sciences (SPSS) version 24.
Results: The study shows a total of 13 patients, with the majority being Malay, male with a median age of 60. 84.6% of the patients were consuming more than 5 medications. While 53.9% of patients fall into CKD stage 4 and 5. Patient’s knowledge towards medications improved significantly with an increase in the median pre-knowledge score of 13 to post knowledge score of 18 (p<0.05) after completion of the session.
Conclusion: From this preliminary evaluation, pharmacist-led medication management clinic resulted in significant improvement of medication knowledge which is further expected to improve medication adherence and delay the disease progression
2. Neuen BL, Chadban SJ, Demaio AR, Johnson DW, Perkovic V, Prince R, et al. Chronic kidney disease and the global NCDs agenda. BMJ Global Health 2017;2:e000380.
3. Manan WW, Wei FC, Rahman FA, Ming LC. Pharmaceutical care to improve medication knowledge among patients with chronic kidney disease. J Pharm Bioall Sci 2016;8:263–4.
4. Tuot DS, Zhu Y, Velasquez A, Espinoza J, Mendez CD, Banerjee T, et al. Variation in patients' awareness of CKD according to how they are asked. CJASN 2016;11:1566–73.
5. Ministry of Health Malaysia. Management of Chronic Kidney Disease in Adults. Complementary Ther Clin Practice 2011;15:1–58.
6. Alrasheedy AA, Hassali MA, Wong ZY, Saleem F. Pharmacist-managed medication therapy adherence clinics: the malaysian experience. Res Soc Administrative Pharm 2017;13:885–8.
7. Ng CY, Lee ZS, Goh KS. Cross-sectional study on knowledge of chronic kidney disease among medical outpatient clinic patients. Med J Malaysia 2016;71:99–104.
8. Zhang Q, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: a systematic review. BMC Public Health 2008;8:117.
9. Tsai WC, Wu HY, Peng Y Sen, Ko MJ, Wu MS, Hung KY. Risk factors for development and progression of chronic kidney disease: a systematic review and exploratory meta-analysis. Medicine (Baltimore) 2016;95:e3013.
10. Al-Ramahi R. Medication prescribing patterns among chronic kidney disease patients in a hospital in Malaysia. Saudi J Kidney Dis Transpl 2012;23:403–8.
11. Ghimirey A, Sapkota B, Shrestha S, Basnet N, Shankar PR, Sapkota S. Evaluation of pharmacist counseling in improving knowledge, attitude, and practice in chronic kidney disease patients. SAGE Open Med 2013;1:205031211351611
12. Baby B, Antony CL, Wilson S, Xavier T, Tamilselvan T. Evaluation of impact of pharmaceutical care on improving knowledge and medication adherence in CKD patients. Int J Pharm Pharm Sci 2016;9:63-6.
13. Salgado TM, Moles R, Benrimoj SI, Fernandez-llimos F. Pharmacists interventions in the management of patients with chronic kidney disease: a systematic review. Nephrol Dial Transplant 2012;27:276-92.
This work is licensed under a Creative Commons Attribution 4.0 International License.